Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9194250 | 0.93 | CYP2C19 (0.56) | CYP2C19HIF1ALMNACYP2C9 | |
| SCHEMBL9194273 | 0.89 | CYP2C19 (0.51) | CYP2C19HIF1ALMNA | |
| SCHEMBL9734504 | 0.88 | CYP2C19 (0.46) | CYP2C19HIF1ALMNA | |
| SCHEMBL9736246 | 0.87 | CYP2C19 (0.45) | CYP2C19HIF1ALMNA | |
| SCHEMBL9563087 | 0.87 | CYP2C19 (0.63) | CYP2C19HIF1ALMNACYP2C9 | |
| SCHEMBL8380649 | 0.82 | CYP2C19 (0.41) | CYP2C19HIF1ALMNA | |
| SCHEMBL9735199 | 0.82 | CYP2C19 (0.42) | CYP2C19HIF1ALMNA | |
| SCHEMBL3425136 | 0.82 | LMNA (0.63) | CYP2C19HIF1ALMNACYP2C9 | |
| SCHEMBL5553113 | 0.81 | CYP2C19 (0.91) | CYP2C19HIF1ALMNACYP2C9 | |
| SCHEMBL9548440 | 0.81 | CYP2C19 (0.40) | CYP2C19HIF1ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022106715-A1 | PROCEDURE FOR OBTAINING HIGH PURITY IOHEXOL | JUSTESA IMAGEN S.A.U. (ES) | 2022-05-27 | — | — | WO | claimed |
| WO-2012097315-A1 | METHOD AND SYSTEM FOR EVALUATING HEMODYNAMICS OF A BLOOD VESSEL | BAYLOR COLLEGE OF MEDICINE (US) | 2012-07-19 | — | — | WO | claimed |
| WO-2022106715-A1 | PROCEDURE FOR OBTAINING HIGH PURITY IOHEXOL | JUSTESA IMAGEN S.A.U. (ES) | 2022-05-27 | — | — | WO | disclosed |
| US-11217435-B2 | Tuned synthetic dendrimer calibrants for mass spectrometry | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2022-01-04 | — | — | US | disclosed |
| US-20200090917-A1 | TUNED SYNTHETIC DENDRIMER CALIBRANTS FOR MASS SPECTROMETRY | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND | 2020-03-19 | — | — | US | disclosed |
| US-10347476-B2 | Tuned synthetic dendrimer calibrants for mass spectrometry | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2019-07-09 | — | — | US | disclosed |
| WO-2017165841-A1 | IODINE-BASED PARTICLES | NANOPROBES, INC. (US) | 2017-09-28 | — | — | WO | disclosed |
| EP-3047271-A1 | METHODS FOR PHENOTYPING OF INTACT WHOLE TISSUES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2016-07-27 | — | — | EP | disclosed |
| US-9186422-B2 | Radio-opaque compounds, compositions containing same and methods of their synthesis and use | PATHAK HOLDINGS LLC (US) | 2015-11-17 | — | — | US | disclosed |
| US-20150132854-A1 | Tuned Synthetic Dendrimer Calibrants for Mass Spectrometry | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND | 2015-05-14 | — | — | US | disclosed |
| WO-2015041755-A1 | METHODS FOR PHENOTYPING OF INTACT WHOLE TISSUES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-03-26 | — | — | WO | disclosed |
| US-20100290995-A1 | RADIO-OPAQUE COMPOUNDS, COMPOSITIONS CONTAINING SAME AND METHODS OF THEIR SYNTHESIS AND USE | PATHAK HOLDINGS LLC | 2010-11-18 | — | — | US | disclosed |
| US-7790141-B2 | Radio-opaque compounds, compositions containing same and methods of their synthesis and use | PATHAK HOLDINGS, LLC (US) | 2010-09-07 | — | — | US | disclosed |
| EP-1748807-A2 | METHOD AND APPARATUS FOR DIRECT MECHANICAL VENTRICULAR ACTUATION WITH FAVORABLE CONDITIONING AND MINIMAL HEART STRESS | Advanced Resuscitation, LLC (US) | 2007-02-07 | — | — | EP | disclosed |
| EP-1644060-A2 | SENSOR-EQUIPPED AND ALGORITHM-CONTROLLED DIRECT MECHANICAL VENTRICULAR ASSIST DEVICE | Advanced Resuscitation, LLC (US) | 2006-04-12 | — | — | EP | disclosed |
| WO-2005091860-A2 | METHOD AND APPARATUS FOR DIRECT MECHANICAL VENTRICULAR ACTUATION WITH FAVORABLE CONDITIONING AND MINIMAL HEART STRESS | ADVANCED RESUSCITATION, LLC. (US) | 2005-10-06 | — | — | WO | disclosed |
| US-20050036946-A1 | Radio-opaque compounds, compositions containing same and methods of their synthesis and use | PATHAK HOLDINGS, LLC | 2005-02-17 | — | — | US | disclosed |
| WO-2005000160-A2 | SENSOR-EQUIPPED AND ALGORITHM-CONTROLLED DIRECT MECHANICAL VENTRICULAR ASSIST DEVICE | ADVANCED RESUSCITATION, LLC (US) | 2005-01-06 | — | — | WO | disclosed |
| US-4396597-A | Process for the preparation of a sterile injectable physiologically acceptable solution of an X-ray contrast agent and solutions of the X-ray contrast agent and a buffer | NYEGAARD & CO. A/S (NO) | 1983-08-02 | — | — | US | disclosed |
| US-4278654-A | Process for the preparation of a sterile injectable physiologically acceptable solution of an X-ray contrast agent and solutions of the X-ray contrast agent and a buffer | NYEGAARD & CO. A/S (NO) | 1981-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11217435-B2 | Tuned synthetic dendrimer calibrants for mass spectrometry | SRMS, SRM, DNMT1 | CYP2C19 4567/4885HIF1A 3855/4885LMNA 2006/4885 |
| US-10347476-B2 | Tuned synthetic dendrimer calibrants for mass spectrometry | SRMS, SRM, DNMT1 | CYP2C19 4626/4885HIF1A 3765/4885LMNA 2090/4885 |
| US-20100290995-A1 | RADIO-OPAQUE COMPOUNDS, COMPOSITIONS CONTAINING SAME AND METHODS OF THEIR SYNTHESIS AND USE | PLOD3, IK, SON | CYP2C19 2605/4885HIF1A 2396/4885LMNA 719/4885 |
| US-20050036946-A1 | Radio-opaque compounds, compositions containing same and methods of their synthesis and use | PLOD3, IK, SON | CYP2C19 2605/4885HIF1A 2396/4885LMNA 719/4885 |
| US-20200090917-A1 | TUNED SYNTHETIC DENDRIMER CALIBRANTS FOR MASS SPECTROMETRY | SRMS, SRM, DNMT1 | CYP2C19 4567/4885HIF1A 3855/4885LMNA 2006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.